 Ramon Lorca
Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vasodilation | 4 | 2020 | 457 | 1.670 |
Why?
| | Altitude | 3 | 2021 | 422 | 1.240 |
Why?
| | Uterine Artery | 5 | 2020 | 65 | 1.240 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 3 | 2017 | 10 | 1.220 |
Why?
| | Arteries | 2 | 2020 | 250 | 1.200 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 2 | 2017 | 9 | 1.110 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2019 | 454 | 1.100 |
Why?
| | Fetal Growth Retardation | 6 | 2020 | 468 | 1.050 |
Why?
| | Myometrium | 3 | 2020 | 35 | 0.990 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channels | 3 | 2018 | 10 | 0.910 |
Why?
| | Placenta | 5 | 2021 | 639 | 0.870 |
Why?
| | Zinc | 4 | 2011 | 262 | 0.790 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2021 | 178 | 0.790 |
Why?
| | Pregnancy | 15 | 2021 | 5691 | 0.750 |
Why?
| | Altitude Sickness | 2 | 2020 | 163 | 0.700 |
Why?
| | Nitric Oxide Synthase | 1 | 2019 | 225 | 0.650 |
Why?
| | Protein Kinases | 1 | 2020 | 310 | 0.640 |
Why?
| | Pre-Eclampsia | 2 | 2019 | 183 | 0.620 |
Why?
| | Uterus | 2 | 2018 | 194 | 0.610 |
Why?
| | Copper | 4 | 2007 | 102 | 0.600 |
Why?
| | CA1 Region, Hippocampal | 2 | 2011 | 30 | 0.480 |
Why?
| | Receptors, Purinergic P2 | 4 | 2007 | 20 | 0.480 |
Why?
| | Placental Circulation | 4 | 2021 | 56 | 0.460 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 907 | 0.430 |
Why?
| | Long-Term Potentiation | 2 | 2011 | 148 | 0.430 |
Why?
| | Hypoxia | 5 | 2021 | 963 | 0.430 |
Why?
| | PPAR gamma | 3 | 2020 | 188 | 0.420 |
Why?
| | Receptors, Purinergic P2X | 2 | 2011 | 6 | 0.420 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2445 | 0.410 |
Why?
| | Signal Transduction | 2 | 2021 | 4709 | 0.340 |
Why?
| | Calcium | 1 | 2014 | 1169 | 0.310 |
Why?
| | Histidine | 2 | 2005 | 63 | 0.280 |
Why?
| | Prions | 2 | 2003 | 36 | 0.280 |
Why?
| | Nitric Oxide | 3 | 2020 | 892 | 0.280 |
Why?
| | HEK293 Cells | 3 | 2017 | 625 | 0.250 |
Why?
| | Purinergic P2 Receptor Antagonists | 2 | 2005 | 5 | 0.250 |
Why?
| | Repetitive Sequences, Amino Acid | 1 | 2003 | 16 | 0.230 |
Why?
| | Nitric Oxide Synthase Type I | 2 | 2020 | 26 | 0.220 |
Why?
| | Animals | 22 | 2021 | 33381 | 0.210 |
Why?
| | Ileum | 2 | 2020 | 100 | 0.210 |
Why?
| | Peptide Fragments | 2 | 2003 | 702 | 0.210 |
Why?
| | RGS Proteins | 2 | 2012 | 12 | 0.210 |
Why?
| | Female | 17 | 2021 | 61565 | 0.210 |
Why?
| | Adenosine Triphosphate | 4 | 2011 | 439 | 0.200 |
Why?
| | Cystathionine gamma-Lyase | 1 | 2020 | 11 | 0.200 |
Why?
| | Patch-Clamp Techniques | 5 | 2013 | 247 | 0.190 |
Why?
| | Structure-Activity Relationship | 2 | 2017 | 522 | 0.190 |
Why?
| | Pyrones | 1 | 2020 | 9 | 0.190 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 40 | 0.190 |
Why?
| | Maternal-Fetal Exchange | 1 | 2021 | 157 | 0.190 |
Why?
| | Mice | 12 | 2020 | 15520 | 0.180 |
Why?
| | Biphenyl Compounds | 1 | 2020 | 52 | 0.180 |
Why?
| | Thiophenes | 1 | 2020 | 106 | 0.180 |
Why?
| | Amino Acids | 2 | 2021 | 465 | 0.180 |
Why?
| | Gastrointestinal Motility | 1 | 2019 | 26 | 0.180 |
Why?
| | Receptors, Purinergic P2X4 | 3 | 2011 | 4 | 0.170 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2016 | 236 | 0.170 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2020 | 140 | 0.170 |
Why?
| | Ion Channel Gating | 2 | 2017 | 85 | 0.170 |
Why?
| | Fetal Hypoxia | 1 | 2019 | 46 | 0.170 |
Why?
| | Endothelin-1 | 1 | 2020 | 168 | 0.160 |
Why?
| | Electrophysiology | 2 | 2011 | 204 | 0.160 |
Why?
| | Rats | 7 | 2019 | 5392 | 0.160 |
Why?
| | Trophoblasts | 1 | 2019 | 170 | 0.160 |
Why?
| | Adaptation, Physiological | 1 | 2021 | 502 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2019 | 420 | 0.150 |
Why?
| | Protein Subunits | 1 | 2018 | 211 | 0.150 |
Why?
| | Birth Weight | 1 | 2019 | 465 | 0.140 |
Why?
| | Trace Elements | 2 | 2007 | 46 | 0.140 |
Why?
| | Adult | 5 | 2021 | 31512 | 0.140 |
Why?
| | alpha-Macroglobulins | 1 | 2016 | 24 | 0.140 |
Why?
| | Xenopus laevis | 3 | 2005 | 128 | 0.140 |
Why?
| | Oocytes | 3 | 2005 | 190 | 0.130 |
Why?
| | Uterine Contraction | 1 | 2014 | 16 | 0.120 |
Why?
| | Humans | 14 | 2021 | 118974 | 0.120 |
Why?
| | Neurons | 3 | 2019 | 1345 | 0.120 |
Why?
| | Calcium Signaling | 1 | 2016 | 219 | 0.120 |
Why?
| | Transcription Factor RelA | 1 | 2014 | 82 | 0.120 |
Why?
| | Kinetics | 1 | 2017 | 1624 | 0.120 |
Why?
| | Fetus | 1 | 2018 | 690 | 0.120 |
Why?
| | Mice, Knockout | 2 | 2018 | 2680 | 0.120 |
Why?
| | Dopaminergic Neurons | 1 | 2013 | 43 | 0.110 |
Why?
| | Microscopy, Confocal | 1 | 2014 | 314 | 0.110 |
Why?
| | Image Enhancement | 1 | 2014 | 181 | 0.110 |
Why?
| | TRPM Cation Channels | 1 | 2013 | 68 | 0.110 |
Why?
| | Natriuretic Peptide, C-Type | 1 | 2012 | 5 | 0.110 |
Why?
| | GTP-Binding Protein gamma Subunits | 1 | 2012 | 8 | 0.110 |
Why?
| | GTP-Binding Protein beta Subunits | 1 | 2012 | 14 | 0.110 |
Why?
| | Mesenteric Arteries | 1 | 2012 | 16 | 0.110 |
Why?
| | Protein Isoforms | 1 | 2014 | 345 | 0.110 |
Why?
| | Microscopy, Fluorescence | 1 | 2014 | 412 | 0.110 |
Why?
| | TRPV Cation Channels | 1 | 2012 | 32 | 0.110 |
Why?
| | Blood Pressure | 1 | 2019 | 1664 | 0.110 |
Why?
| | Maze Learning | 2 | 2009 | 86 | 0.100 |
Why?
| | Peptides | 1 | 2017 | 879 | 0.100 |
Why?
| | Hyperalgesia | 1 | 2012 | 108 | 0.100 |
Why?
| | Purinergic P2X Receptor Agonists | 1 | 2011 | 1 | 0.100 |
Why?
| | Purinergic P2X Receptor Antagonists | 1 | 2011 | 6 | 0.100 |
Why?
| | Receptors, Purinergic P2X7 | 1 | 2011 | 10 | 0.100 |
Why?
| | Zebrafish Proteins | 1 | 2013 | 252 | 0.100 |
Why?
| | Parasympathetic Fibers, Postganglionic | 1 | 2010 | 1 | 0.100 |
Why?
| | Protein Kinase C | 1 | 2012 | 297 | 0.100 |
Why?
| | Receptors, GABA-A | 1 | 2011 | 89 | 0.090 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2009 | 10 | 0.090 |
Why?
| | Phenylephrine | 2 | 2020 | 85 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 3 | 2011 | 2478 | 0.090 |
Why?
| | Zebrafish | 1 | 2013 | 434 | 0.090 |
Why?
| | Excitatory Postsynaptic Potentials | 1 | 2010 | 105 | 0.090 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 191 | 0.090 |
Why?
| | Motor Activity | 1 | 2013 | 660 | 0.080 |
Why?
| | Receptors, AMPA | 1 | 2010 | 125 | 0.080 |
Why?
| | Membrane Potentials | 2 | 2007 | 253 | 0.080 |
Why?
| | Central Nervous System Stimulants | 1 | 2009 | 142 | 0.080 |
Why?
| | Allosteric Site | 1 | 2007 | 17 | 0.080 |
Why?
| | Space Perception | 2 | 2009 | 65 | 0.080 |
Why?
| | Drug Synergism | 2 | 2005 | 339 | 0.080 |
Why?
| | Action Potentials | 1 | 2010 | 420 | 0.080 |
Why?
| | Young Adult | 2 | 2019 | 10793 | 0.070 |
Why?
| | Heart Rate | 1 | 2010 | 729 | 0.070 |
Why?
| | Synapses | 1 | 2010 | 344 | 0.070 |
Why?
| | Heart | 1 | 2010 | 631 | 0.070 |
Why?
| | Cell Differentiation | 1 | 2013 | 1753 | 0.070 |
Why?
| | Vasoconstrictor Agents | 2 | 2020 | 122 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2009 | 1945 | 0.070 |
Why?
| | Receptors, Purinergic P2X2 | 1 | 2005 | 16 | 0.070 |
Why?
| | Nerve Tissue Proteins | 1 | 2010 | 551 | 0.070 |
Why?
| | Risk Factors | 1 | 2019 | 9000 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2016 | 4077 | 0.070 |
Why?
| | Phosphorylation | 2 | 2020 | 1633 | 0.070 |
Why?
| | Extracellular Space | 1 | 2005 | 127 | 0.060 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2005 | 363 | 0.060 |
Why?
| | Mice, Inbred C57BL | 4 | 2019 | 4908 | 0.060 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2005 | 536 | 0.060 |
Why?
| | Membrane Proteins | 1 | 2010 | 1055 | 0.060 |
Why?
| | Microinjections | 1 | 2003 | 83 | 0.060 |
Why?
| | Binding Sites | 2 | 2005 | 1224 | 0.060 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2003 | 55 | 0.060 |
Why?
| | Chelating Agents | 1 | 2003 | 74 | 0.060 |
Why?
| | Mutation | 4 | 2019 | 3457 | 0.060 |
Why?
| | Amino Acid Substitution | 1 | 2003 | 276 | 0.050 |
Why?
| | Homeostasis | 2 | 2020 | 594 | 0.050 |
Why?
| | Memory | 1 | 2003 | 230 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2021 | 48 | 0.050 |
Why?
| | Adolescent | 1 | 2019 | 18480 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 982 | 0.050 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2020 | 11 | 0.050 |
Why?
| | Ribonucleotides | 1 | 2020 | 26 | 0.050 |
Why?
| | Glycolysis | 1 | 2021 | 224 | 0.050 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2020 | 48 | 0.050 |
Why?
| | Male | 7 | 2019 | 57801 | 0.050 |
Why?
| | Lactic Acid | 1 | 2021 | 282 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2020 | 3730 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2020 | 104 | 0.040 |
Why?
| | Cyclic GMP | 1 | 2019 | 109 | 0.040 |
Why?
| | Acetylcholine | 1 | 2020 | 208 | 0.040 |
Why?
| | Alanine | 1 | 2019 | 102 | 0.040 |
Why?
| | RNA | 1 | 2005 | 833 | 0.040 |
Why?
| | Glutathione | 1 | 2020 | 324 | 0.040 |
Why?
| | Sheep | 1 | 2021 | 764 | 0.040 |
Why?
| | Thiazolidinediones | 1 | 2020 | 146 | 0.040 |
Why?
| | Middle Aged | 1 | 2019 | 27617 | 0.040 |
Why?
| | Muscle, Smooth | 1 | 2019 | 157 | 0.040 |
Why?
| | Biological Transport | 1 | 2019 | 382 | 0.040 |
Why?
| | Estrogens | 1 | 2020 | 328 | 0.040 |
Why?
| | Vasodilator Agents | 1 | 2020 | 328 | 0.040 |
Why?
| | Placental Insufficiency | 1 | 2019 | 104 | 0.040 |
Why?
| | Mice, Transgenic | 2 | 2012 | 2025 | 0.040 |
Why?
| | Oxygen | 1 | 2021 | 854 | 0.040 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2016 | 14 | 0.040 |
Why?
| | Pregnancy Trimester, Third | 1 | 2016 | 69 | 0.030 |
Why?
| | Cell Line | 2 | 2013 | 2707 | 0.030 |
Why?
| | Regional Blood Flow | 1 | 2017 | 418 | 0.030 |
Why?
| | Brain | 1 | 2007 | 2490 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1691 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2014 | 139 | 0.030 |
Why?
| | 1-Methyl-4-phenylpyridinium | 1 | 2013 | 5 | 0.030 |
Why?
| | Deferoxamine | 1 | 2013 | 17 | 0.030 |
Why?
| | Electroretinography | 1 | 2013 | 41 | 0.030 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2013 | 70 | 0.030 |
Why?
| | Cyclooxygenase 2 | 1 | 2014 | 168 | 0.030 |
Why?
| | Melanocytes | 1 | 2013 | 66 | 0.030 |
Why?
| | Tetraethylammonium | 1 | 2012 | 15 | 0.030 |
Why?
| | Larva | 1 | 2013 | 213 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2010 | 2071 | 0.030 |
Why?
| | Potassium Channel Blockers | 1 | 2012 | 30 | 0.030 |
Why?
| | Ganglia, Spinal | 1 | 2012 | 45 | 0.030 |
Why?
| | DNA Primers | 1 | 2013 | 533 | 0.030 |
Why?
| | Hippocampus | 2 | 2010 | 735 | 0.030 |
Why?
| | Naphthalenes | 1 | 2012 | 41 | 0.030 |
Why?
| | Angiotensin II | 1 | 2012 | 107 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2010 | 2871 | 0.030 |
Why?
| | Indoles | 1 | 2014 | 316 | 0.030 |
Why?
| | Toll-Like Receptor 4 | 1 | 2014 | 330 | 0.030 |
Why?
| | Vasoconstriction | 1 | 2012 | 213 | 0.020 |
Why?
| | Receptor, Muscarinic M2 | 1 | 2010 | 8 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2010 | 75 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2014 | 870 | 0.020 |
Why?
| | RNA Interference | 1 | 2012 | 460 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1293 | 0.020 |
Why?
| | Hot Temperature | 1 | 2012 | 334 | 0.020 |
Why?
| | Sinoatrial Node | 1 | 2010 | 32 | 0.020 |
Why?
| | Bradycardia | 1 | 2010 | 49 | 0.020 |
Why?
| | Models, Biological | 1 | 2017 | 1715 | 0.020 |
Why?
| | Swimming | 1 | 2009 | 46 | 0.020 |
Why?
| | Blotting, Western | 1 | 2012 | 1194 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2010 | 336 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2010 | 372 | 0.020 |
Why?
| | Visual Perception | 1 | 2009 | 141 | 0.020 |
Why?
| | Neuronal Plasticity | 1 | 2009 | 219 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2009 | 1094 | 0.020 |
Why?
| | Serotonin | 1 | 2009 | 309 | 0.020 |
Why?
| | Allosteric Regulation | 1 | 2007 | 85 | 0.020 |
Why?
| | Brain Chemistry | 1 | 2007 | 119 | 0.020 |
Why?
| | Ion Channels | 1 | 2007 | 126 | 0.020 |
Why?
| | Blood-Brain Barrier | 1 | 2007 | 108 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2012 | 1597 | 0.020 |
Why?
| | Toxicity Tests | 1 | 2005 | 26 | 0.020 |
Why?
| | Extracellular Fluid | 1 | 2005 | 32 | 0.020 |
Why?
| | Metals, Heavy | 1 | 2005 | 22 | 0.020 |
Why?
| | Protein Conformation | 1 | 2007 | 848 | 0.020 |
Why?
| | Evoked Potentials | 1 | 2005 | 115 | 0.020 |
Why?
| | Injections, Intraventricular | 1 | 2003 | 73 | 0.010 |
Why?
| | Neurotoxins | 1 | 2003 | 27 | 0.010 |
Why?
| | Cysteine | 1 | 2005 | 184 | 0.010 |
Why?
| | Protein Binding | 1 | 2007 | 1975 | 0.010 |
Why?
| | Astrocytes | 1 | 2003 | 177 | 0.010 |
Why?
| | Aging | 1 | 2009 | 1670 | 0.010 |
Why?
| | Time Factors | 1 | 2009 | 6412 | 0.010 |
Why?
|
|
Lorca's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|